NCT02148120View on ClinicalTrials.gov

A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Asthma
Interventions
DRUG

Beclometasone Dipropionate 100 µg + Formoterol Fumarate 6 µg

DRUG

Beclometasone Dipropionate 200 µg + Formoterol Fumarate 6 µg

DRUG

Placebo

Trial Locations (3)

NW10 7EW

Hammersmith Medicines Research, London

W1G 8HU

Respiratory Clinical Trials, Hearth Lung Centre, London

M23 9QZ

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02148120 - A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler | Biotech Hunter | Biotech Hunter